Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04260048 · ClinicalTrials.gov registry record
Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 101
- Enrollment target
NCT04260048: Completed study, sponsored by University of Washington.
NCT04260048 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04260048 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study during which they will complete 5 in-person study visits.
Primary Outcome
Evidence of hypothalamic gliosis as measured by T2 relaxation time using MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-02-21 |
| Est. Completion | 2024-05-30 |
What the finished NCT04260048 record still lists
NCT04260048 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04260048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04260048 about?
NCT04260048 is a clinical study titled "Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children". BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study durin...
What is the current status of trial NCT04260048?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2020-02-21. Estimated completion is 2024-05-30.
Who is sponsoring clinical trial NCT04260048?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI